GA4GH has unveiled its new strategic plan for the next five years, which hopes to improve and define genomic data sharing standards on an international level
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
Articles on ResearchGate have been found to breach publishers’ copyright, and must remove millions of papers after the filing of a lawsuit.
Beijing has announced new rules that will help speed up approvals of medicine and ease bottlenecks when introducing new treatments.
After revealing to the press that Theranos’ medical claims were false, Tyler Shultz has announced the launch of his new start-up, Flux Biosciences.
The first gene therapy for cancer, approved by the FDA in August, will transform the treatment process, but it will bring both hope and challenges.
Alnylam Pharmaceuticals has announced positive results from its latest phase 3 clinical trials of patisiran, the company’s lead drug.
Nineteen patients have died from taking a liver-disease drug from Intercept, the FDA has warned doctors about the risk from the product.
Earlier this year Roche’s immune-oncology drug Tecentriq failed a bladder cancer trial, putting a conditional approval by the FDA in jeopardy. But the threat has since been dissolved.